Excelsior Sciences
PrivateLast Round
Series A
Dec 3, 2025
Est. Valuation
$96M
Total Funding Raised
$70M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Excelsior Sciences operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series A round in December 2025.
Excelsior Sciences is a biotechnology company that develops an automated chemistry platform and a machine-native chemical language to accelerate the discovery and manufacturing of small molecules.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Excelsior Sciences Comparables
Compare Excelsior Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DeepCure | 87% | |
| Synfini | 86% | |
| Iktos | 80% |
For institutional investors. Book with your work email.
Excelsior Sciences Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Excelsior Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MIT | Series A |
| Deerfield Management | Series A |
| Cornucopian Capital | Series A |
| Khosla Ventures | Series A |
| Empire State Development | Series A |
| Sofinnova Partners | Series A |
| Illinois Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 14, 2026
Monthly visitors increased 38% MoM.
- Aug 20, 2026
Monthly visitors grew 64% MoM, reaching 3.2K.
For institutional investors. Book with your work email.
Excelsior Sciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Excelsior Sciences's valuation, stock price, and market status.
Is Excelsior Sciences a public or private company?
Excelsior Sciences is a private company.
What is the current stock price of Excelsior Sciences?
Excelsior Sciences is a private company, so its shares have no public market price. Caplight tracks Excelsior Sciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Excelsior Sciences worth (valuation)?
Excelsior Sciences's valuation is estimated at $96.0M based on funding round data.
Can I buy Excelsior Sciences stock?
Excelsior Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Excelsior Sciences's last funding round?
Excelsior Sciences's most recent funding round was Series A on December 3, 2025.
Who are the main investors in Excelsior Sciences?
Key investors in Excelsior Sciences include Deerfield Management, Khosla Ventures, Sofinnova Partners.
Will Excelsior Sciences IPO soon?
No public IPO plans have been announced for Excelsior Sciences.
How can I track Excelsior Sciences secondary market activity?
Caplight tracks bids, offers, and trades in Excelsior Sciences's shares on secondary markets.